title: 5-thiomannosides block the biosynthesis of dolichol-linked oligosaccharides and mimic class I congenital disorders of glycosylation.
abstract: In a cell-based assay for novel inhibitors, we have discovered that two glycosides of 5-thiomannose, each containing an interglycosidic nitrogen atom, prevented the correct zymogen processing of the prohormone proopiomelanocortinin (POMC) and the transcription factor sterol-regulatory element-binding protein-2 (SREBP-2) in mouse pituitary cells and Chinese hamster ovary (CHO) cells, respectively. In the case of SREBP-2, these effects were correlated with the altered N-linked glycosylation of subtilisin/kexin-like isozyme-1 (SKI-1), the protease responsible for SREBP-2 processing under sterol-limiting conditions. Further examination of the effects of these compounds in CHO cells showed that they cause extensive protein hypoglycosylation in a manner similar to type I congenital disorders of glycosylation (CDGs) since the remaining N-glycans in treated cells were complete (normal) structures. The under-glycosylation of glycoproteins in 5-thiomannoside-treated cells is now shown to be caused by the compromised biosynthesis of the dolichol-linked oligosaccharide (DLO) N-glycosylation donor, although the nucleotide sugars required for the synthesis of DLOs were neither reduced under these conditions, nor were their effects reversed upon the addition of exogenous mannose. Analysis of DLO intermediates by fluorophore-assisted carbohydrate electrophoresis demonstrated that 5-thiomannose-containing glycosides block DLO biosynthesis most likely at a stage prior to the GlcNAc(2) Man(3)  intermediate, on the cytosolic face of the endoplasmic reticulum.
authors.affiliation: Department of Chemistry, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
authors.forename: Wesley F
authors.initials: WF
authors.lastname: Zandberg
authors.forename: Ningguo
authors.initials: N
authors.lastname: Gao
authors.forename: Jayakanthan
authors.initials: J
authors.lastname: Kumarasamy
authors.forename: Mark A
authors.initials: MA
authors.lastname: Lehrman
authors.forename: Nabil G
authors.initials: NG
authors.lastname: Seidah
authors.forename: B Mario
authors.initials: BM
authors.lastname: Pinto
mesh_terms: D000818:Animals; D016466:CHO Cells; D002478:Cells, Cultured; D018981:Congenital Disorders of Glycosylation / Q000378:metabolism* / Q000517:prevention & control; D006224:Cricetinae; D004195:Disease Models, Animal; D004286:Dolichols / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000737:chemistry; D008358:Mannose / Q000031:analogs & derivatives / Q000737:chemistry / Q000494:pharmacology*; D051379:Mice; D009844:Oligosaccharides / Q000037:antagonists & inhibitors* / Q000096:biosynthesis / Q000737:chemistry
chemical_list: D004286:Dolichols; D009844:Oligosaccharides; D008358:Mannose